Innoviva, Inc. beat EPS estimates 69% of the time across 16 reported quarters (11 beats, 5 misses), averaging +24.5% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.56 | $0.59 | +5.4% | Beat | |
| Q1 FY26 | $0.43 | $0.44 | +2.3% | Beat | |
| Q4 FY25 | not reported | $1.94 | not reported | not reported | |
| Q3 FY25 | $0.46 | $1.08 | +134.8% | Beat | |
| Q2 FY25 | $0.57 | $0.77 | +35.1% | Beat | |
| Q1 FY25 | not reported | $0.25 | not reported | not reported | |
| Q4 FY24 | not reported | $0.57 | not reported | not reported | |
| Q3 FY24 | not reported | $0.02 | not reported | not reported | |
| Q2 FY24 | not reported | $0.68 | not reported | not reported | |
| Q1 FY24 | not reported | $0.46 | not reported | not reported | |
| Q4 FY23 | not reported | $0.76 | not reported | not reported | |
| Q3 FY23 | not reported | $0.98 | not reported | not reported |
Back to INVA overview · INVA holders · INVA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.